Become the domain experts on the FIZE kUO and other FIZE devices in hospitals, outpatient settings, nursing homes etc., to facilitate introduction and utilization of these devices in all of these settings, and to lead and perform research on the devices and outcomes related to their clinical use for publication in peer reviewed journals.
Urologists are the primary experts in the selection, insertion, and maintenance of Foley catheters. They serve as valuable resources to physicians and healthcare providers, offering insights on the FIZE kUO device, looking to improve the management of patients with indwelling catheters.
To support this initiative, FIZE Medical has created the “FIZE Urology Council.” Led by Dr. Neal Shore and Dr. Steve Kaplan, the council aims to build a network of urologists across the United States who will conduct clinical research and validate the use of the FIZE kUO device, ultimately enhancing patient safety and care.
Dr. Steven Kaplan is the Director of the Men’s Wellness Program at Mount Sinai Health System and a Professor at the Icahn School of Medicine at Mount Sinai. He is a leading expert in benign prostatic diseases, metabolic factors related to voiding dysfunction, and female urology concerning benign prostate enlargement and bladder function.
As a Diplomat of the American Board of Urology and a Fellow of the American College of Surgeons, Dr. Kaplan has published over 1,000 works, including 600 peer-reviewed articles and 90 book chapters. His landmark 2006 study in JAMA revolutionized the treatment of benign prostate symptoms. He has presented more than 340 times in over 35 countries and co-authored five books.
Dr. Kaplan is a member of over 30 professional organizations and has received five NIH grants totaling over $13 million in research funding. He has served on multiple NIH study sections and currently chairs the AUA Research Committee on Advocacy. He received the John K. Lattimer Award for Lifetime Achievement in Urology from the National Kidney Foundation.
Previously, he was at Weill Cornell Medical College, where he developed Integrated Men’s Health and directed the Fellowship Program in Male and Female Voiding Dysfunction. He graduated from the Mount Sinai School of Medicine in 1982 and completed his residency training at Mount Sinai Hospital and Columbia University. Dr. Kaplan was an American Urologic Association Scholar from 1988 to 1990, focusing on bladder and prostate dysfunction
Neal Shore graduated from Duke University and Duke University Medical School. He completed his residency in general surgery and urology at New York Hospital-Cornell Medical Center and Memorial Sloan Kettering Cancer Center. Currently, he is the Medical Director of the Carolina Urologic Research Center and the Chief Medical Officer for Urology and Surgical Oncology at GenesisCare, US.
Dr. Shore has conducted over 400 clinical trials focused on genitourinary oncology and authored more than 250 peer-reviewed publications. He serves on the Society for Immunotherapy of Cancer (SITC) Guidelines Committee for Bladder Cancer and is involved with the boards of the Bladder Cancer Advocacy Network and the Duke Global Health Institute. Additionally, he chairs both the Prostate Cancer Academy and the Bladder/Kidney Cancer Academy for LUGPA/Specialty Network.
